Analysis of redox and apoptotic effects of anthracyclines to delineate a cardioprotective strategy

Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation

(2014) Yoshihiko Ichikawa et al.   JOURNAL OF CLINICAL INVESTIGATION

Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer

(2013) Melissa M. Hudson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Treatment-related cardiotoxicity in survivors of childhood cancer

(2013) Steven E. Lipshultz et al.   Nature Reviews Clinical Oncology

Anthracyclines and Heart Failure

(2013) Douglas B. Sawyer   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation of Short-Term Use of N-Acetylcysteine as a Strategy for Prevention of Anthracycline-Induced Cardiomyopathy: EPOCH Trial - A Prospective Randomized Study

(2013) Sang-Ho Jo et al.   Korean Circulation Journal

Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection

(2012) Martin Štěrba et al.   ANTIOXIDANTS & REDOX SIGNALING

Cardiotoxicity of a non-pegylated liposomal doxorubicin-based regimen versus an epirubicin-based regimen for breast cancer: The LITE (Liposomal doxorubicin–Investigational chemotherapy–Tissue doppler imaging Evaluation) randomized pilot study

(2012) Marzia Lotrionte et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

(2012) Sui Zhang et al.   NATURE MEDICINE

Clinical trials of antioxidants as cancer prevention agents: Past, present, and future

(2011) Michael Goodman et al.   FREE RADICAL BIOLOGY AND MEDICINE

Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group

(2011) Javier G. Blanco et al.   JOURNAL OF CLINICAL ONCOLOGY

Anthracyclines and ellipticines as DNA-damaging anticancer drugs: Recent advances

(2011) Rene Kizek et al.   PHARMACOLOGY & THERAPEUTICS